LES INHIBITEURS COMPETITIFS DE L'ANGIOTENSINE IICHAMONTIN B; SALVADOR M; GUITTARD J et al.1980; THERAPIE; ISSN 0040-5957; FRA; DA. 1980; VOL. 35; NO 5; PP. 637-640; BIBL. 18 REF.Article

SYSTEMIC HEMODYNAMICS AND HORMONAL RESPONSES DURING ANGIOTENSIN II BLOCKADE WITH SARALASINROOS JC; GEYSKES GG; BOER P et al.1981; J. CARDIOVASC. PHARMACOL.; ISSN 0160-2446; USA; DA. 1981; VOL. 3; NO 5; PP. 1106-1115; BIBL. 28 REF.Article

THE INFLUENCE OF SARALA ANGIOTENSIN II (SARALASIN) ON PLASMA ALDOSTERONE IN HYPERTENSIVE PATIENTSDONKER AJM; VAN HOOGDALEM P; PRATT JJ et al.1979; ACTA MED. SCAND.; SWE; DA. 1979; VOL. 205; NO 3; PP. 207-212; BIBL. 21 REF.Article

INHIBITION OF THE RENIN-ANGIOTENSIN SYSTEM. A NEW APPROACH TO THE THERAPY OF HYPERTENSIONONDETTI MA; CUSHMAN DW.1981; J. MED. CHEM.; ISSN 0022-2623; USA; DA. 1981; VOL. 24; NO 4; PP. 355-361; BIBL. 61 REF.Article

SARALASINA ED IPERTENSIONE ARTERIOSA A BASSA RENINEMIA = SARALASINE ET HYPERTENSION ARTERIELLE AVEC RENINEMIE BASSEFRISINA N; BUEMI M; LASCO A et al.1980; BOLL. SOC. ITAL. BIOL. SPER.; ITA; DA. 1980; VOL. 56; NO 13; PP. 1367-1373; ABS. ENG; BIBL. 14 REF.Article

EFFECT OF ENDOGENOUS ANGIOTENSIN ON THE EFFERENT GLOMERULAR ARTERIOLE OF RAT KIDNEYFREGA NS; DAVALOS M; LEAF A et al.1980; KIDNEY INT.; ISSN 0085-2538; USA; DA. 1980; VOL. 18; NO 3; PP. 323-327; ABS. FRE; BIBL. 25 REF.Article

EFFECT OF ANGIOTENSION II ANTAGONIST-SAR¹, ILE⁸ ON THE DEVELOPMENT OF ARTERIAL HYPERTENSION IN SHRDIMITROV TG; KIPROV DI; MILEVA TB et al.1979; C.R. ACAD. BULG. SCI.; BGR; DA. 1979; VOL. 32; NO 6; PP. 843-846; BIBL. 6 REF.Article

EFFECT OF SAR¹-ALU⁸-ANGIOTENSIN II ON BLOOD PRESSURE AND RENIN IN BARTTER'S SYNDROME, BEFORE AND AFTER TREATMENT WITH PROSTAGLANDIN SYNTHETASE INHIBITORSRUDIN A; AURELL M; HANSSON L et al.1979; SCAND. J. CLIN. LAB. INVEST.; NOR; DA. 1979; VOL. 39; NO 6; PP. 543-550; BIBL. 33 REF.Article

ACQUISITIONS RECENTES DANS LE TRAITEMENT DE L'HYPERTENSION ARTERIELLE: LES ANTAGONISTES DU SYSTEME RENINE-ANGIOTENSINE, LES NOUVEAUX VASODILATATEURS ET LES AGONISTES DOPAMINERGIQUESANDREJAK M; HARDIN JM; MAKDASSI R et al.1979; REV. MED. PICARDIE; FRA; DA. 1979; VOL. 7; NO 9; PP. 241-245; BIBL. 22 REF.Article

CONTRASTS AND SIMILARITIES OF ACUTE HEMODYNAMIC RESPONSES TO SPECIFIC ANTAGONISM OF ANGIOTENSIN II ((SAR¹, THR⁸)AII) AND TO INHIBITION OF CONVERTING ENZYME (CAPTOPRIL)FOUAD FM; CEIMO JMK; TARAZI RC et al.1980; CIRCULATION; USA; DA. 1980; VOL. 61; NO 1; PP. 163-169; BIBL. 36 REF.Article

SARALASIN^REG. INFUSION IN RENOVASCULAR AND ESSENTIAL HYPERTENSIONTHIEN T; HOEFNAGELS WHL.1980; NETHERL. J. MED.; NLD; DA. 1980; VOL. 23; NO 2; PP. 68-73; BIBL. 21 REF.Article

THE EFFECTS OF ANGIOTENSIN II BLOCKADE AND NEPHRECTOMY ON THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN THE NEWBORN LAMBSIEGEL SR; FISHER DA.1979; PEDIATR. RES.; USA; DA. 1979; VOL. 13; NO 5 PART. 1; PP. 603-605; BIBL. 22 REF.Article

ORGAN SELECTIVE ANGIOTENSIN ANTAGONISTS: SARCOSYL¹-CYSTEINYL (S-METHYL)⁸-ANGIOTENSIN IFREER RJ; SUTHERLAND JC JR; DAY AR et al.1980; EUROP. J. PHARMACOL.; NLD; DA. 1980; VOL. 65; NO 4; PP. 349-354; BIBL. 18 REF.Article

COMPARISON BETWEEN SARALASIN AND CONVERTING ENZYME INHIBITOR IN HYPERTENSIVE DISEASECASE DB; WALLACE JM; LARAGH JH et al.1979; KIDNEY INTERACTION., SUPPL.; DEU; DA. 1979; NO 9; PP. 107-114; BIBL. 20 REF.Article

USE OF CONTINUOUS SARALASIN INFUSION TO CONTROL HYPERTENSIONRULEY EJ; BOCK GH; SMITH D et al.1982; JOURNAL OF PEDIATRICS; ISSN 0022-3476; USA; DA. 1982; VOL. 101; NO 6; PP. 1013-1017; BIBL. 13 REF.Article

SCREENING OF ANGIOTENSIN II DEPENDENT HYPERTENSIVE PATIENTS USING A LINEAR CLASSIFIERKOIVO AJ.1981; MED. INFORM.; ISSN 0307-7640; GBR; DA. 1981; VOL. 6; NO 1; PP. 19-24; ABS. FRE; BIBL. 5 REF.Article

EFFECTS OF ANGIOTENSIN II AND OF AN ANGIOTENSIN II RECEPTOR ANTAGONIST ON SIMIAN VIRUS 40-INDUCED TUMOR GROWTH IN VIVOSCHELLING P; GANTEN D; NEMES Z et al.1980; EXPERIENTIA; CHE; DA. 1980; VOL. 36; NO 4; PP. 452-454; BIBL. 17 REF.Article

ANGIOTENSIN II BLOCKADE DURING COMBINED THIAZIDE-BETA -BLOCKER TREATMENTIBSEN H; LETH A; MCNAIR A et al.1980; SCAND. J. CLIN. LAB. INVEST.; NOR; DA. 1980; VOL. 40; NO 4; PP. 325-331; BIBL. 32 REF.Article

PHARMACOLOGIC INTERRUPTION OF THE RENIN-ANGIOTENSIN SYSTEMHOLLENBERG NK.1979; ANNU. REV. PHARMACOL. TOXICOL.; USA; DA. 1979; NO 19; PP. 559-582; BIBL. 117 REF.Article

IMPIEGO DELLA SARALASIMA NEI SOGGETTI UREMICI IPERTESI IN TRATTAMENTO EMODIALITICO PERIODICO = EMPLOI DE LA SARALASINE CHEZ DES SUJETS ATTEINTS D'UREMIE ET D'HYPERTENSION, TRAITES PAR HEMODIALYSE PERIODIQUECAPELLI G; VAGGE R; LAMPERI S et al.1979; MINERVA NEFROL.; ITA; DA. 1979; VOL. 26; NO 1; PP. 5-8; ABS. ENG; BIBL. 14 REF.Article

Angiotensin Receptor Blockers : Current Status and Future ProspectsRAM, C. Venkata S.The American journal of medicine. 2008, Vol 121, Num 8, pp 656-663, issn 0002-9343, 8 p.Article

Angiotensin II-receptor blocker dosages : How high should we go?DÜSING, R.International journal of clinical practice (Esher). 2006, Vol 60, Num 2, pp 179-183, issn 1368-5031, 5 p.Article

Increased Capillary Branching Contributes to Angiotensin Type 1 Receptor Blocker (ARB)―Induced Regression of SclerosisSCRUGGS, Benjamin S; YIQIN ZUO; DONNERT, Ellen et al.The American journal of pathology. 2011, Vol 178, Num 4, pp 1891-1898, issn 0002-9440, 8 p.Article

EFFECT OF ANGIOTENSIN II ON IN VIVO AND IN VITRO RELEASE OF ANTERIOR PITUITARY HORMONES IN THE FEMALE RATSTEELE MK; NEGRO VILAR A; MCCANN SM et al.1981; ENDOCRINOLOGY (PHILADELPHIA); ISSN 0013-7227; USA; DA. 1981; VOL. 109; NO 3; PP. 893-899; BIBL. 34 REF.Article

EFFECT OF SARALASIN AND INDOMETHACIN ON RENAL FUNCTION IN DEVELOPING PIGLETSOSBORN JL; HOOK JB; BAILIE MD et al.1980; AMER. J. PHYSIOL., REGULAT. INTEGRAT. COMP. PHYSIOL.; USA; DA. 1980; VOL. 7; NO 3; PP. R438-R442; BIBL. 20 REF.Article